This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Rising on Huge Volume

Impax Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Impax Laboratories (IPXL - Get Report) is a technology-based, specialty pharmaceutical company applying formulation and development expertise, as well as its drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. This stock is trading up 6.7% at $20.16 in recent trading.

Today's Volume: 858,000

Average Volume: 534,669

Volume % Change: 137%

Shares of IPXL are soaring today after the company announced it obtained the U.S. rights to AstraZeneca PLC's migraine headache drug Zomig.

From a technical standpoint, IPXL bounced big right off its 50-day moving average today at $19.41, and it briefly traded above its 200-day moving average of $20.64 on big volume.

Market players should now watch for the next big breakout trade to trigger in IPXL once this stock moves above $21.68 to $22.07 with volume. Look for volume that's near or above 534,669 if we that breakout soon.

Impax shows up on recent lists of 8 Pharma Stocks to Watch and 5 Bargain Biotech Stocks.
3 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ZIGO $0.00 0.00%
DNDN $0.06 -6.02%
CVLT $38.19 0.00%
CLNE $2.42 0.00%
FSYS $4.03 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs